280 related articles for article (PubMed ID: 15857879)
1. Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis.
Nestaas E; Bangstad HJ; Sandvik L; Wathne KO
Arch Dis Child Fetal Neonatal Ed; 2005 Jul; 90(4):F294-300. PubMed ID: 15857879
[TBL] [Abstract][Full Text] [Related]
2. Extended-interval aminoglycoside administration for children: a meta-analysis.
Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
[TBL] [Abstract][Full Text] [Related]
3. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
Prescott WA
Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
[TBL] [Abstract][Full Text] [Related]
4. Validation of a dosage individualization table for extended-interval gentamicin in neonates.
Dersch-Mills D; Akierman A; Alshaikh B; Yusuf K
Ann Pharmacother; 2012; 46(7-8):935-42. PubMed ID: 22739714
[TBL] [Abstract][Full Text] [Related]
5. Application of Bayes theorem to aminoglycoside-associated nephrotoxicity: comparison of extended-interval dosing, individualized pharmacokinetic monitoring, and multiple-daily dosing.
Kim MJ; Bertino JS; Erb TA; Jenkins PL; Nafziger AN
J Clin Pharmacol; 2004 Jul; 44(7):696-707. PubMed ID: 15199074
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides.
Bailey TC; Little JR; Littenberg B; Reichley RM; Dunagan WC
Clin Infect Dis; 1997 May; 24(5):786-95. PubMed ID: 9142771
[TBL] [Abstract][Full Text] [Related]
7. Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis.
Hatala R; Dinh T; Cook DJ
Ann Intern Med; 1996 Apr; 124(8):717-25. PubMed ID: 8633831
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of extended-interval aminoglycoside administration in pediatric patients.
Kraus DM; Pai MP; Rodvold KA
Paediatr Drugs; 2002; 4(7):469-84. PubMed ID: 12083974
[TBL] [Abstract][Full Text] [Related]
9. Performance of a dosage individualization table for extended interval gentamicin in neonates beyond the first week of life.
Dersch-Mills D; Akierman A; Alshaikh B; Sundaram A; Yusuf K
J Matern Fetal Neonatal Med; 2016; 29(9):1451-6. PubMed ID: 26043646
[TBL] [Abstract][Full Text] [Related]
10. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients.
Koo J; Tight R; Rajkumar V; Hawa Z
Am J Med; 1996 Aug; 101(2):177-83. PubMed ID: 8757358
[TBL] [Abstract][Full Text] [Related]
11. Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.
Prescott WA; Nagel JL
Pharmacotherapy; 2010 Jan; 30(1):95-108. PubMed ID: 20030477
[TBL] [Abstract][Full Text] [Related]
12. Adaptation in neonatology of the once-daily concept of aminoglycoside administration: evaluation of a dosing chart for amikacin in an intensive care unit.
Langhendries JP; Battisti O; Bertrand JM; François A; Kalenga M; Darimont J; Scalais E; Wallemacq P
Biol Neonate; 1998 Nov; 74(5):351-62. PubMed ID: 9742264
[TBL] [Abstract][Full Text] [Related]
13. Single or multiple daily doses of aminoglycosides: a meta-analysis.
Barza M; Ioannidis JP; Cappelleri JC; Lau J
BMJ; 1996 Feb; 312(7027):338-45. PubMed ID: 8611830
[TBL] [Abstract][Full Text] [Related]
14. Extended dosage intervals for aminoglycosides.
Rodman DP; Maxwell AJ; McKnight JT
Am J Hosp Pharm; 1994 Aug; 51(16):2016-21. PubMed ID: 7977422
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring.
Croes S; Koop AH; van Gils SA; Neef C
Eur J Pharm Sci; 2012 Jan; 45(1-2):90-100. PubMed ID: 22094306
[TBL] [Abstract][Full Text] [Related]
16. What is the evidence for once-daily aminoglycoside therapy?
Barclay ML; Begg EJ; Hickling KG
Clin Pharmacokinet; 1994 Jul; 27(1):32-48. PubMed ID: 7955770
[TBL] [Abstract][Full Text] [Related]
17. Once daily versus multiple daily dosing with intravenous aminoglycosides for cystic fibrosis.
Tan K; Bunn H
Cochrane Database Syst Rev; 2000; (4):CD002009. PubMed ID: 11034740
[TBL] [Abstract][Full Text] [Related]
18. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
Graham AC; Mercier RC; Achusim LE; Pai MP
Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688
[TBL] [Abstract][Full Text] [Related]
19. [Optimalisation of netilmicin dosage based on therapeutic drug monitoring during the first days of life in very preterm neonates (gestational age 23-32 weeks)].
Rutkowska M; Kamińska E; Piekarczyk A; Nowicka K; Polak K; Nowakowska-Szyrwińska E; Szamotulska K
Med Wieku Rozwoj; 2009; 13(4):252-9. PubMed ID: 20081273
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring of aminoglycosides in neonates.
Touw DJ; Westerman EM; Sprij AJ
Clin Pharmacokinet; 2009; 48(2):71-88. PubMed ID: 19271781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
